112-9437436-1/1/1

Novartis Pharmaceuticals Corporation — FEI 2210396

Refusal Details

Date
March 30, 2017
Country
United States
Product Category
Drugs and Biologics
Product Code
66VCO99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75